Check out the latest CMIC White Papers! CMIC Group is contract research organization supporting companies in pharmaceutical developments.
The Japan market is often viewed as a difficult market [...]
Bioanalysis is critical for advancing R&D across the drug development [...]
Software as a medical device (SaMD) is a new wave [...]
As the pharma industry looks beyond the West, Japan and [...]
Explore key trends and challenges in the clinical trial landscape [...]
ICH M10 is the first-ever global set of guidelines for [...]
Fallout from the COVID-19 pandemic, global unrest, and more are [...]
Recent advances in genetic analytic technologies like next generation sequencing [...]
Japan represents an attractive and largely untapped market for each [...]
As pressures increase to get drugs to market faster, developers [...]
The industry is turning towards real-world data to create more [...]
Rare diseases have smaller patient populations, which make drug development [...]
The Latest Insights into Clinical Studies in Japan The Pharma [...]
Expanding to Asia can be a logical next step for [...]
Digital therapeutics (DTx) are evolving rapidly. Many now provide drug-like [...]
© CMIC HOLDINGS Co., LTD. All rights reserved.
Never miss an update – Click below to receive emails on CMIC‘s global services, latest news, & more!
Click Here to Sign Up
